Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-omics analysis in suspected hereditary breast and ovarian cancer cases reveals novel candidate susceptibility factors.

NPJ breast cancer·2026
Same author

Exploring the potential of Gonolobus condurango as a histone deacetylase inhibitor in triple-negative breast cancer cell lines: in vitro study.

BMC complementary medicine and therapies·2025
Same author

Genomic variant profiling in blast-phase paediatric chronic myeloid leukaemia: Predisposing and driving alterations.

British journal of haematology·2025
Same author

A Novel <i>Alu</i> Element Insertion in <i>ATM</i> Induces Exon Skipping in Suspected HBOC Patients.

Human mutation·2025
Same author

Influence of Cytogenetics on the Outcome of Patients With High-Risk Myelodysplastic Syndrome Including Deletion 5q Treated With Azacitidine With or Without Lenalidomide.

Genes, chromosomes & cancer·2025
Same author

Deciphering the needs of patients with hereditary breast and ovarian Cancer in the Process of Genetic Counseling to Inform the Development of a Mobile Support App: a qualitative study in Germany.

Journal of community genetics·2024

Related Experiment Video

Updated: Jun 11, 2026

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Aberrant microRNA expression pattern in myelodysplastic bone marrow cells.

Kais Hussein1, Katharina Theophile, Guntram Büsche

  • 1Institute of Pathology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. Hussein.Kais@MH-Hannover.de

Leukemia Research
|July 15, 2010
PubMed
Summary

MicroRNAs, small RNA molecules, show distinct expression patterns in myelodysplastic syndromes (MDS). This study reveals unique microRNA profiles in MDS, differentiating it from non-cancerous cells.

More Related Videos

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Related Experiment Videos

Last Updated: Jun 11, 2026

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Area of Science:

  • Molecular Biology
  • Genetics
  • Hematology

Background:

  • MicroRNA (miR) dysregulation is implicated in cellular homeostasis and disease.
  • Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.

Purpose of the Study:

  • To profile microRNA expression in myelodysplastic syndromes (MDS) with varying cytogenetic aberrations.
  • To investigate the role of microRNAs in MDS pathogenesis and hematopoiesis.

Main Methods:

  • Expression profiling of 365 microRNAs in 24 MDS patients (12 normal karyotype, 12 with cytogenetic aberrations).
  • Analysis of microRNA expression in relation to specific chromosomal abnormalities (del(5q), -7, +8).

Main Results:

  • Identified a distinct microRNA expression pattern in MDS compared to non-neoplastic cells.
  • Observed increased expression of specific microRNAs outside the deleted 5q region in MDS-del(5q).
  • Found no differential expression of microRNAs encoded on chromosomes 5, 7, or 8 in specific MDS subtypes.

Conclusions:

  • MicroRNA expression profiles are significantly altered in MDS.
  • These findings suggest microRNAs play a role in the distinct hematopoiesis observed in MDS.
  • Further validation in larger cohorts is warranted to confirm specific microRNA up-regulation, such as miR-1.